Assignee
OXIGENE INC
US·17 granted patents·3 pending applications·168 citations·filing 1994–2014
Top patents by PatentIndex Score
20 records- 0193US6538038B1Compositions and methods for use in targeting vascular destructionOXIGENE INC·Filed 2000·Granted Mar 25, 2003·63 cites·12 claims
- 0283US7384925B2Functionalized stilbene derivatives as improved vascular targeting agentsOXIGENE INC·Filed 2005·Granted Jun 10, 2008·6 cites·8 claims
- 0377US8877967B2Compositions and methods for inhibition of cathepsinsOXIGENE INC·Filed 2013·Granted Nov 4, 2014·4 cites·20 claims
- 0474US7358236B1Control of acute hypertension and cardiotoxicity in patients treated with vascular targeting agentsOXIGENE INC·Filed 2003·Granted Apr 15, 2008·5 cites·13 claims
- 0573US9458103B2Compositions and methods for inhibition of cathepsinsOXIGENE INC·Filed 2014·Granted Oct 4, 2016·2 cites·8 claims
- 0673US6773702B2Use of combretastatin A4 and its prodrugs as an immune enhancing therapyOXIGENE INC·Filed 2001·Granted Aug 10, 2004·5 cites·13 claims
- 0773US6020351ACarotenoid-nicotinamide-zinc compositions and methods of treatment using sameOXIGENE INC·Filed 1996·Granted Feb 1, 2000·32 cites·13 claims
- 0870US6956054B2Compositions and methods for use in targeting vascular destructionOXIGENE INC·Filed 2002·Granted Oct 18, 2005·4 cites·16 claims
- 0963US2009192098A1Method for treating hematopoietic neoplasmsOXIGENE INC·Filed 2008·Application pending·0 cites
- 1062US6339073B1Uses of nicotinamide adenine dinucleotide and its derivatives for treatment of malignant and infectious diseasesOXIGENE INC·Filed 1998·Granted Jan 15, 2002·18 cites·6 claims
- 1161USRE45720EFunctionalized stilbene derivatives as improved vascular targeting agentsOXIGENE INC·Filed 2014·Granted Oct 6, 2015·0 cites·12 claims
- 1259USRE45907EFunctionalized stilbene derivatives as improved vascular targeting agentsOXIGENE INC·Filed 2014·Granted Mar 1, 2016·0 cites·8 claims
- 1359US6743937B2Efficient method of synthesizing combretastatin A-4 prodrugsOXIGENE INC·Filed 2001·Granted Jun 1, 2004·4 cites·32 claims
- 1455US2011110940A1Methods for Enhancing the Efficacy of Vascular Disrupting AgentsOXIGENE INC·Filed 2009·Application pending·0 cites
- 1554US6028111ACompositions and use of benzamides and nicotinamides as anti-inflammatory agentsOXIGENE INC·Filed 1997·Granted Feb 22, 2000·11 cites·10 claims
- 1650US6100299AN-acetyl 3-chloroprocainamide, acid addition salts thereof, and methods of useOXIGENE INC·Filed 1998·Granted Aug 8, 2000·8 cites·9 claims
- 1742US2009137687A1Compositions and Methods With Enhanced Therapeutic ActivityOXIGENE INC·Filed 2008·Application pending·0 cites
- 1838US5561129AMethods of administering phenothiazines and/or acid addition salts thereofOXIGENE INC·Filed 1995·Granted Oct 1, 1996·2 cites·8 claims
- 1935US5561161AMethods of administering and pharmaceutical formulations containing n-substituted benzamides and/or acid addition salts thereofOXIGENE INC·Filed 1994·Granted Oct 1, 1996·3 cites·27 claims
- 2030US6713517B1Use of aryl N-substituted carboxamides directly and as radio-and chemosensitizers for killing tumor and cancer cells and novel compounds for such useOXIGENE INC·Filed 1997·Granted Mar 30, 2004·1 cites·3 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →